Cognitive impairment can occur in cancer patients who are treated with a variety of therapies, including radiation therapy, hormone therapy, and chemotherapy. After chemotherapy treatment it is commonly called "chemo brain." ...
May 13, 2015
0
4
Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during and after treatment. ...
May 8, 2015
0
21
Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn't take statins, a clinical ...
May 7, 2015
0
23
There's nothing like napping on the couch during a lazy weekend or lounging cozily while watching your favorite sporting event on television.
May 1, 2015
0
5
Preliminary results of a study of patients with prostate cancer show that MR tractography may be a reliable quantitative imaging biomarker to assess prostate cancer treatment response to androgen deprivation and radiation ...
Apr 24, 2015
0
6
(HealthDay)—For patients with prostate cancer, androgen deprivation therapy (ADT) has a lasting impact on physical function, according to a study published online March 24 in Cancer.
Mar 31, 2015
0
5
(HealthDay)—Age, race, and other factors may influence treatment decisional regret among men with prostate cancer, according to research published online March 3 in Cancer.
Mar 11, 2015
0
3
(HealthDay)—For men with prostate cancer (PCa), the risk for incident cardiovascular disease (CVD) is increased with androgen deprivation therapy (ADT), according to a study published online March 2 in the Journal of Clinical ...
Mar 11, 2015
0
6
(HealthDay)—Cholesterol-lowering statin drugs may slow down prostate cancer in men who are also taking medication to reduce their levels of male hormones, according to new research.
Mar 10, 2015
0
30
Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. The German Institute for Quality and Efficiency ...
Jan 8, 2015
0
21
